These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 33939248)

  • 1. Bioenergetic and inflammatory systemic phenotypes in Alzheimer's disease APOE ε4-carriers.
    Wilkins HM; Wang X; Menta BW; Koppel SJ; Bothwell R; Becker AM; Anderson H; Schwartz E; Pei D; Yellapu NK; Chalise P; Gouvion CM; Haeri M; Burns JM; Swerdlow RH
    Aging Cell; 2021 May; 20(5):e13356. PubMed ID: 33939248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet cytochrome oxidase and citrate synthase activities in APOE ε4 carrier and non-carrier Alzheimer's disease patients.
    Wilkins HM; Koppel SJ; Bothwell R; Mahnken J; Burns JM; Swerdlow RH
    Redox Biol; 2017 Aug; 12():828-832. PubMed ID: 28448944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of APOE, age at onset, amyloid and clinical phenotype in Alzheimer disease.
    Whitwell JL; Tosakulwong N; Weigand SD; Graff-Radford J; Ertekin-Taner N; Machulda MM; Duffy JR; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Josephs KA;
    Neurobiol Aging; 2021 Dec; 108():90-98. PubMed ID: 34551374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOE epsilon4 is a high-risk factor for Alzheimer's disease in the Mongolian population.
    Huriletemuer ; Wang B; Wang J; Wang G; Zhang C; Zhao S; Zhou S; Ma X; Wang de S
    J Neurol Sci; 2010 Jan; 288(1-2):167-9. PubMed ID: 19819468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory Pathways Are Impaired in Alzheimer Disease and Differentially Associated With Apolipoprotein E Status.
    Kloske CM; Dugan AJ; Weekman EM; Winder Z; Patel E; Nelson PT; Fardo DW; Wilcock DM
    J Neuropathol Exp Neurol; 2021 Oct; 80(10):922-932. PubMed ID: 34486652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.
    Martinez M; Campion D; Brice A; Hannequin D; Dubois B; Didierjean O; Michon A; Thomas-Anterion C; Puel M; Frebourg T; Agid Y; Clerget-Darpoux F
    Arch Neurol; 1998 Jun; 55(6):810-6. PubMed ID: 9626772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
    Mattila KM; Rinne JO; Röyttä M; Laippala P; Pietilä T; Kalimo H; Koivula T; Frey H; Lehtimäki T
    J Med Genet; 2000 Oct; 37(10):766-70. PubMed ID: 11015454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCA7 polymorphisms correlate with memory impairment and default mode network in patients with APOEε4-associated Alzheimer's disease.
    Chang YT; Hsu SW; Huang SH; Huang CW; Chang WN; Lien CY; Lee JJ; Lee CC; Chang CC
    Alzheimers Res Ther; 2019 Dec; 11(1):103. PubMed ID: 31831047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.
    Licastro F; Porcellini E; Caruso C; Lio D; Corder EH
    Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between the APOE Genotype and Possible Plasma Biomarkers in Alzheimer's Disease.
    Zverova M; Kitzlerova E; Fisar Z; Jirak R; Hroudova J; Benakova H; Lelkova P; Martasek P; Raboch J
    Curr Alzheimer Res; 2018; 15(10):938-950. PubMed ID: 29852871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EEG functional connectivity and ApoE genotype in Alzheimer's disease and controls.
    Kramer G; van der Flier WM; de Langen C; Blankenstein MA; Scheltens P; Stam CJ
    Clin Neurophysiol; 2008 Dec; 119(12):2727-32. PubMed ID: 18848805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Aβ
    Wang HY; Trocmé-Thibierge C; Stucky A; Shah SM; Kvasic J; Khan A; Morain P; Guignot I; Bouguen E; Deschet K; Pueyo M; Mocaer E; Ousset PJ; Vellas B; Kiyasova V
    Alzheimers Res Ther; 2017 Jul; 9(1):54. PubMed ID: 28750690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population.
    Kim HC; Kim DK; Choi IJ; Kang KH; Yi SD; Park J; Park YN
    Psychiatry Clin Neurosci; 2001 Apr; 55(2):115-20. PubMed ID: 11285089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of APOE epsilon4 allele on cerebral glucose metabolism in AD is a function of age at onset.
    Hirono N; Hashimoto M; Yasuda M; Ishii K; Sakamoto S; Kazui H; Mori E
    Neurology; 2002 Mar; 58(5):743-50. PubMed ID: 11889238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease patients not carrying the apolipoprotein E ε4 allele show more severe slowing of oscillatory brain activity.
    de Waal H; Stam CJ; de Haan W; van Straaten EC; Blankenstein MA; Scheltens P; van der Flier WM
    Neurobiol Aging; 2013 Sep; 34(9):2158-63. PubMed ID: 23587637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linking APOE-ε4, blood-brain barrier dysfunction, and inflammation to Alzheimer's pathology.
    Riphagen JM; Ramakers IHGM; Freeze WM; Pagen LHG; Hanseeuw BJ; Verbeek MM; Verhey FRJ; Jacobs HIL
    Neurobiol Aging; 2020 Jan; 85():96-103. PubMed ID: 31733942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease.
    Drigalenko E; Poduslo S; Elston R
    Neurology; 1998 Jul; 51(1):131-5. PubMed ID: 9674791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.